Sweden's Bure Equity 9M NAV per share rises on portfolio gains

Overview

• Sweden investment firm's net asset value per share rose 34.8% in first nine months

• Group earnings after tax and EPS turned positive from losses a year earlier

• Company highlighted strong portfolio gains, value adjustments and a SEK 19 mln divestment

Outlook

• Company did not provide specific financial guidance for future quarters or full-year results

Result Drivers

• PORTFOLIO GAINS - Co cited strong share price increases in Yubico, Mycronic and Vitrolife as key drivers of net asset value growth

• MYCRONIC PERFORMANCE - Mycronic reported sales growth of 38% with all business areas showing double-digit growth, boosting order intake and financial results

• UNLISTED ASSET VALUE ADJUSTMENTS - Positive value adjustment of SEK 225 mln mainly from Atle Investment Management and Nodica Group based on improved sales, profits and transactions

Company press release:

Key Details

Reuters Recommended Reads

• Nov 5 - Sweden's Yubico Q3 net sales rise; appoints insider as deputy CEO

• Nov 3 - Neostellar Capital Q3 NAV per share falls 6%

• Nov 4 - Foresight Solar Fund Q3 NAV per share falls as discount rates increase

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)